Trial Profile
Effect of Diacerein in the Metabolic Control of Patients With Diabetes Mellitus Type 2 and Secondary Failure to Metformin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jul 2017
Price :
$35
*
At a glance
- Drugs Diacerein (Primary)
- Indications Type 2 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- Sponsors ANS Pharma
- 12 Jul 2017 New trial record